Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Greece
  4. ATHENS STOCK EXCHANGE
  5. Lavipharm S.A.
  6. Summary
    LAVI   GRS246073001

LAVIPHARM S.A.

(LAVI)
  Report
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Athens Stock Exchange
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
0.45(c) 0.478(c) 0.49(c) 0.53(c) 0.56(c) Last
28 550 22 980 118 300 198 855 58 670 Volume
-2.60% +6.22% +2.51% +8.16% +5.66% Change
More quotes
Estimated financial data (e)
Sales 2019 33,6 M 38,0 M 38,0 M
Net income 2019 5,33 M 6,03 M 6,03 M
Net Debt 2019 38,9 M 44,1 M 44,1 M
P/E ratio 2019 2,11x
Yield 2019 -
Sales 2020 37,6 M 42,6 M 42,6 M
Net income 2020 2,17 M 2,45 M 2,45 M
Net Debt 2020 37,5 M 42,4 M 42,4 M
P/E ratio 2020 11,1x
Yield 2020 -
Capitalization 28,6 M 32,4 M 32,4 M
EV / Sales 2019 1,49x
EV / Sales 2020 1,63x
Nbr of Employees 263
Free-Float 42,9%
More Financials
Company
Lavipharm SA is a Greek commercial and industrial enterprise engaged in the development, manufacture, marketing and distribution of pharmaceutical, cosmetic and over-the-counter (OTC) products. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about LAVIPHARM S.A.
11/22LAVIPHARM S A : Announcement 9142/2021 (no English translation available)
PU
09/29Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
05/10LAVIPHARM S A : Peania, May 10th 2021 - It is with great sadness that the family of Laviph..
PU
04/26Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
04/26Lavipharm S.A. Auditor Raises 'Going Concern' Doubt
CI
2020LAVIPHARM S A : Peania, December 15th, 2020 – Lavipharm supports the causes of the A..
PU
2020ZENTIVA S A : reinforces its presence in Greece to better serve Greek people
AQ
2020Zentiva Reinforces Its Presence in Greece by Signing A Partnership with the Company Lav..
CI
2020Lavipharm S.A. Auditor Raises 'Going Concern' Doubt
CI
2020LAVIPHARM S A : Announcement 1523/2020 (no English translation available)
PU
2020LAVIPHARM S A : Announcement 1298/2020 (no English translation available)
PU
2020LAVIPHARM S A : Announcement 1149/2020 (no English translation available)
PU
2020LAVIPHARM S A : Announcement 984/2020 (no English translation available)
PU
2020LAVIPHARM S A : Announcement 800/2020 (no English translation available)
PU
2020LAVIPHARM S A : Announcement 407/2020 (no English translation available)
PU
More news
News in other languages on LAVIPHARM S.A.

- No features available -

More news
Chart LAVIPHARM S.A.
Duration : Period :
Lavipharm S.A. Technical Analysis Chart | LAVI | GRS246073001 | MarketScreener
Income Statement Evolution
Managers and Directors
Athanase Lavidas Chairman & Chief Executive Officer
Spiros Magliveras Group Chief Financial Officer
Spyridon Fotinos Chief Scientific Officer
Panagiotis Giannouleas Chief Operating Officer & Country Manager
Christos Panagiotis Diamantopoulos Independent Non-Executive Director